Tony Butler
Stock Analyst at Rodman & Renshaw
(0.57)
# 4,161
Out of 5,152 analysts
88
Total ratings
27.38%
Success rate
-22.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $5.00 | +400.00% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.56 | +605.13% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.37 | +1,213.87% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $2.56 | +525.00% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.38 | +624.64% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $57.33 | +30.82% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.47 | +12,665.96% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $2.05 | +534.15% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $5.35 | +834.58% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $2.31 | +549.35% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.17 | +14,789.82% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.35 | +1,011.11% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.00 | +150.00% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.66 | +2,471.86% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.92 | +5,584.93% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.04 | +752.27% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.74 | +13,693.10% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.20 | +2,948.78% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.63 | +57,051.93% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.78 | -28.06% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.91 | +1,553.99% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.39 | +619.42% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.53 | +171.25% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $13.15 | +736.50% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $12.76 | +7,423.51% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $5.00
Upside: +400.00%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.56
Upside: +605.13%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.37
Upside: +1,213.87%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $2.56
Upside: +525.00%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.38
Upside: +624.64%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $57.33
Upside: +30.82%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.47
Upside: +12,665.96%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.05
Upside: +534.15%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $5.35
Upside: +834.58%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.31
Upside: +549.35%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.17
Upside: +14,789.82%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.35
Upside: +1,011.11%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $4.00
Upside: +150.00%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $0.66
Upside: +2,471.86%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.92
Upside: +5,584.93%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.04
Upside: +752.27%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.74
Upside: +13,693.10%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.20
Upside: +2,948.78%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.63
Upside: +57,051.93%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.78
Upside: -28.06%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $0.91
Upside: +1,553.99%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.39
Upside: +619.42%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.53
Upside: +171.25%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $13.15
Upside: +736.50%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $12.76
Upside: +7,423.51%